Clinical Trial Update: Effect of Estradiol+Drospirenone Versus Estradiol+MPA on Endothelial Function [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing estradiol with drospirenone to estradiol with medroxyprogesterone acetate, evaluating endothelial function; results were posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Drugs mentioned

• Drospirenone (Drospirenone)
• ESTRADIOL (Estradiol)
• Medroxyprogesterone acetate (Medroxyprogesterone acetate)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Cardiovascular Diseases | Phase 4 | Status: COMPLETED | Results posted: 2013-05-03